About
Point-of-care Testing Device for Cancer Detection
OncoRedox is developing a Point-of-care testing device for cancer detection based on ‘Redox-omics’ analysis of urine samples. The technology is based on biochemical electrodes detecting redox metabolic signature using an AI analysis model.
Identity
| Name | OncoRedox |
|---|---|
| Slug | oncoredox |
| Type / kind | startup |
| Source _id | CtBWDP941KS0UTz4GCBIPLokmlNaJrLCaejfW79Bv9siNBLr9TxYmO |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ city | Or Yehuda |
| HQ address | Or Yehuda, Israel |
Web & social
| Website | https://www.oncoredox.com/ |
|---|---|
| https://www.linkedin.com/company/90860822 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Technologies
Artificial IntelligenceBiologicals
Target customers
Healthcare & Life SciencesHealthcareProviders
Business models
B2B
Tags
cancer-diagnosticsdiagnosticsmedical-devices
Funding
| Total raised | $890K |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}